Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence and risk factors of brain metastases in radically resected melanoma patients: a large international cohort study.

ESMO open·2026
Same author

TNAP expressing adventitial pericytes contribute to myogenesis during foetal development.

Vascular pharmacology·2025
Same author

Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI).

ESMO open·2025
Same author

Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2024
Same author

The role of environmental sensitivity, traumatic experiences, defense mechanisms and mental pain on central sensitivity: testing a path analysis model in chronic headache on quality of life.

Psychology, health & medicine·2024
Same author

Illness representation in patients with multiple sclerosis: A preliminary narrative medicine study.

Multiple sclerosis journal - experimental, translational and clinical·2024

Related Experiment Video

Updated: Jun 21, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Risk factors in medication-overuse headache: a 1-year follow-up study (care II protocol).

G Sances1, N Ghiotto, F Galli

  • 1Headache Unit & University Centre for Adaptive Disorders and Headache, University of Pavia, Pavia, Italy. grazia.sances@mondino.it

Cephalalgia : an International Journal of Headache
|July 21, 2009
PubMed
Summary
This summary is machine-generated.

Medication-overuse headache (MOH) relapse is predicted by high drug intake, smoking, alcohol, and returning to overused medications. Identifying these risk factors can improve treatment strategies for patients with MOH.

More Related Videos

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies
05:49

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

Published on: November 1, 2024

Related Experiment Videos

Last Updated: Jun 21, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies
05:49

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

Published on: November 1, 2024

Area of Science:

  • Neurology
  • Clinical Medicine
  • Pharmacology

Background:

  • Medication-overuse headache (MOH) poses a significant challenge in headache management.
  • Understanding prognostic factors is crucial for effective treatment and relapse prevention in MOH patients.

Purpose of the Study:

  • To identify factors influencing prognosis and relapse in patients with probable medication-overuse headache (MOH).
  • To analyze predictors for headache resolution and sustained withdrawal after inpatient detoxification.

Main Methods:

  • A 12-month follow-up study of 215 patients admitted for inpatient detoxification treatment for probable MOH.
  • Analysis of prognostic factors including demographics, primary headache type, psychiatric comorbidity, and medication overuse patterns.
  • Statistical analysis using Mann-Whitney U-test and chi-squared test.

Main Results:

  • A 1-year relapse rate of 22% was observed in 172 patients with complete data.
  • Negative prognostic factors for relapse included high monthly drug intake (>30 doses), smoking, alcohol consumption, and confirmed MOH diagnosis post-detoxification.
  • Returning to overused medications was a significant predictor of relapse (P = 0.000).

Conclusions:

  • Sub-groups of MOH patients with specific risk factors require tailored treatment strategies.
  • Identifying predictors like high drug intake, lifestyle factors, and diagnostic confirmation is key to managing MOH prognosis.
  • The study highlights the importance of sustained withdrawal and addresses modifiable risk factors to improve long-term outcomes in MOH.